Evotec AG (EVTG.DE)
Wed, Apr 18 2018
* DGAP-NEWS: EVOTEC AND BAYER ADVANCE THIRD ENDOMETRIOSIS PROGRAMME INTO PHASE I CLINICAL DEVELOPMENT Source text for Eikon: Further company coverage:
* SAYS PLANS CONVERSION INTO EUROPEAN COMPANY Source text for Eikon: Further company coverage: (Reporting by Frankfurt Newsroom)
PARIS Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this area, led by Evotec.
- Danielle On The Financial Survival Network
- Retirement: Where Could You Invest Your Cash Today?
- Equity CEFs: Confusion Leads To Another Opportunity In ETG
- February: Contrarian Closed-End Funds Opportunities Abound
- 2018's YYY/CEFL Index: Summary Of Changes And Post-Rebalancing Reversion
- Construct A Crash Resistant Income Portfolio